in silico

News

scientifically visualization of a coronavirus spike protein

Gates Foundation backs COVID R&D at AI firm Exscientia

Artificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an award by the Bill & Melinda Gates Foundation.

Events

4070_CDD_For_Biologics_Event_Banner_800x450

Partner Content

3rd Annual Computational Drug Development (CDD) for Biologic...

CDD for Biologics | 13-15 November 2018 | Boston, USA

Events

Partner Content

CDD for Biologics Summit 2017

Optimizing The Development Of Biologics

Gates Foundation backs COVID R&D at AI firm Exscientia

3rd Annual Computational Drug Development (CDD) for Biologic...

CDD for Biologics Summit 2017

23andMe study explains variable results with obesity drugs

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks